首页|多索茶碱联合止喘灵口服液治疗慢性阻塞性肺疾病急性发作期的疗效及对肺功能、炎症因子水平的影响

多索茶碱联合止喘灵口服液治疗慢性阻塞性肺疾病急性发作期的疗效及对肺功能、炎症因子水平的影响

扫码查看
目的 探讨多索茶碱联合止喘灵口服液治疗慢性阻塞性肺疾病急性发作期的效果.方法 选取 2022 年 1月—2023 年12 月江苏洪泽区人民医院收治的 200 例慢性阻塞性肺疾病急性发作期患者为研究对象,按随机数字表法将其分为对照组和研究组,每组 100 例.对照组采用多索茶碱治疗,研究组在对照组基础上采用止喘灵口服液治疗.比较两组的临床疗效、肺功能、炎症因子水平、不良反应发生情况.结果 研究组治疗总有效率为 92.00%,高于对照组的81.00%,差异有统计学意义(P<0.05);治疗后,研究组第 1 秒用力呼气容积(FEV1)、用力肺活量(FVC)均大于对照组,FEV1/FVC高于对照组,血清白细胞介素-6、C反应蛋白水平均低于对照组,组间差异有统计学意义(P<0.05).两组不良反应发生率比较,差异无统计学意义(P>0.05).结论 多索茶碱联合止喘灵口服液治疗慢性阻塞性肺疾病急性发作期患者,可改善患者肺功能,同时降低炎症因子水平,具有较高安全性,疗效显著.
Effect of Doxofylline Combined with Zhichuan Ling Oral Liquid on Pulmonary Function and Inflammatory Factors Levels During Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Objective To investigate the effect of doxofylline combined with Zhichuan Ling oral liquid in the treatment of acute exacerbation of chronic obstructive pulmonary disease.Methods A total of 200 patients with acute exacerbation of chronic obstructive pulmonary disease admitted to Jiangsu Hongze District People's Hospital from January 2022 to December 2023 were selected as the research objects.They were divided into a control group and a research group according to the random number table method,with 100 cases in each group.The control group was treated with doxofylline,and the research group was treated with Zhichuan Ling oral liquid on the basis of the control group.The clinical efficacy,pulmonary function,inflammatory factors levels and adverse reaction were compared between the two groups.Results The total effective rate of the research group was which was 92.00%,higher than 81.00%of the control group,and the difference was statistically significant(P<0.05);after treatment,the forced expiratory volume for 1 second(FEV1),forced vital capacity(FVC)were greater than those of the control group,FEV1/FVC of the research group was higher than that of the control group,and the levels of serum interleukin-6 and C-reactive protein were lower than those of the control group,and the differences between the groups were statistically significant(P<0.05);the incidence of adverse reactions between the two groups was compared,and the difference was no statistically significant(P>0.05).Conclusion Doxofylline combined with Zhichuan Ling oral liquid can improve pulmonary function and reduce inflammatory factors levels in patients with acute exacerbation of chronic obstructive pulmonary disease,with high safety and significant efficacy.

Chronic obstructive pulmonary diseaseAcute exacerbationZhichuan ling oral liquidDoxofylline

赵娜、唐平平、朱文静

展开 >

江苏洪泽区人民医院呼吸与危重症医学科,江苏淮安 223100

江苏洪泽区人民医院康复医学科,江苏淮安 223100

慢性阻塞性肺疾病 急性发作 止喘灵口服液 多索茶碱

2024

反射疗法与康复医学

反射疗法与康复医学

ISSN:
年,卷(期):2024.5(13)